Respiratory disease testing helps in the diagnosis of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and others. Various products used in respiratory disease testing include spirometers, peak flow meters, polysomnography devices, gas analyzers, and other pulmonary function testing devices. These products help test the functioning of lungs and detect abnormalities. With the increasing prevalence of chronic respiratory diseases owing to pollution and changing lifestyles, the need for early detection through proper respiratory disease testing has risen.

The global Respiratory Disease Testing Market is estimated to be valued at US$ 3232 Mn in 2023 and is expected to exhibit a CAGR of 6.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The rising number of chronic respiratory disease cases is the major factor accelerating the growth of the respiratory disease testing market. Chronic respiratory diseases cause long-term health problems. According to the Global Burden of Disease Study, COPD affected over 174.5 million people worldwide in 2017. Also, around 339 million people globally suffered from asthma in 2018. Regular screening through respiratory disease testing plays a vital role in early disease detection and effective management of chronic respiratory diseases. This is increasing the demand for various respiratory disease testing products globally. Companies are also developing innovative portable respiratory diagnostic devices for home healthcare settings in order to increase early disease detection. This trend is expected to continue during the forecast period.

Segment Analysis
The global respiratory disease testing market is dominated by molecular diagnostic testing segment with around 50% market share. Molecular diagnostic tests are highly sensitive and can detect respiratory pathogens at their genetic level in a short duration compared to other conventional tests. These tests can identify multiple respiratory infections simultaneously with high accuracy, thus making them a preferred choice for diagnosing respiratory diseases.

Key Takeaways
The Global Respiratory Disease Testing Market Share is expected to witness high growth over the forecast period of 2023 to 2030. The market is projected to grow at a CAGR of around 6% during the forecast period and reach a market size of over US$ 5200 Mn by 2030.

Regional analysis

North America currently dominates the global respiratory disease testing market with over 35% share. High awareness regarding early diagnosis of respiratory diseases and strong presence of leading market players in the region driving the market growth. The Asia Pacific region is expected to witness fastest growth owing to growing healthcare expenditure, increasing patient pool of respiratory diseases due to rising pollution levels and growing preference for point-of-care testing in countries like India and China.

Key players

Key players operating in the respiratory disease testing market include Annandale Distillery, Rocky Mountain Barrel Company, Exotic Barrels, Esty Inc., Midwest Barrel Co., Mystic Barrels, Red Head Barrels, Kentucky Bourbon Barrel (Independent Stave Company), Country Connection, and Kelvin Cooperage. Annandale Distillery maintains its leading position through continuous product innovation and expansions. Other players are focussed on new product launches and geographical expansions to strengthen their market presence.\

Explore more information on this topic, Please visit @   https://www.dailyprbulletin.com/respiratory-disease-testing-market-is-expected-to-driven-by-rising-air-pollution-levels